The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake

Pharmacology Biochemistry and Behavior

Volumn 84, Issue 2, 2006, Pages 353-359

  Thornton Jones, Zoë D ^a   Kennett, Guy A ^b   Benwell, Karen R ^b   Revell, Dean F ^b   Misra, Anil ^b   Sellwood, Daniel M ^b   Vickers, Steven P ^b   Clifton, Peter G ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b Vernalis PLC   (United Kingdom)

Author keywords

Adiponectin; Body weight; DIO rat; Food intake; Paired feeding; Rimonabant; SR141716A

Indexed keywords

ADIPONECTIN; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; MESSENGER RNA; RIMONABANT; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; ENERGY EXPENDITURE; FEEDING; FOOD INTAKE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RAT; TREATMENT OUTCOME; WEIGHT REDUCTION; ANIMAL; BIOSYNTHESIS; BLOOD; DRUG ANTAGONISM; EATING; FAT INTAKE; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALIA;

ADIPONECTIN; ANIMALS; BODY WEIGHT; DIETARY FATS; EATING; MALE; OBESITY; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1;

EID: 33746490030     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.06.001     Document Type: Article

References (39)

1. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
2. Bensaid M., Gary-Bobo M., Esclangon A., Maffrand J.P., Le Fur G., Oury-Donat F., et al. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol Pharmacol 63 (2003) 908-914
3. Berg A.H., Combs T.P., and Scherer P.E. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13 (2002) 84-89
4. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
5. Colombo G., Agabio R., Diaz G., Lobina C., Reali R., and Gessa G.L. Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci 63 (1998) 113-117
6. Combs T.P., Berg A.H., Rajala M.W., Klebanov S., Iyengar P., Jimenez-Chillaron J.C., et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 52 (2003) 268-276
7. Cota D., Marsicano G., Tschop M., Grubler Y., Flachskamm C., Schubert M., et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112 (2003) 423-431
8. De Vry J., Schreiber R., Eckel G., and Jentzsch K.R. Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A. Eur J Pharmacol 483 (2004) 55-63
9. Di Marzo V., Goparaju S.K., Wang L., Liu J., Batkai S., Jarai Z., et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410 (2001) 822-825
10. Farrell D.J., and Williams V.J. Calorimetric measurements made on rats during repeated periods of weight gain and weight loss. Comp Biochem Physiol 94A (1989) 61-67
11. Fruebis J., Tsao T.S., Javorschi S., Ebbets-Reed D., Erickson M.R., Yen F.T., et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 98 (2001) 2005-2010
12. Higgs S., Williams C.M., and Kirkham T.C. Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716. Psychopharmacology (Berl) 165 (2003) 370-377
13. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20 (2000) 1595-1599
14. Hu E., Liang P., and Spiegelman B.M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271 (1996) 10697-10703
15. Jamshidi N., and Taylor D.A. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol 134 (2001) 1151-1154
16. Kirkham T.C. Endocannabinoids in the regulation of appetite and body weight. Behav Pharmacol 16 (2005) 297-313
17. Kirkham T.C., Williams C.M., Fezza F., and Di Marzo V. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136 (2002) 550-557
18. Matsuzawa Y., Shimomura I., Kihara S., and Funahashi T. Importance of adipocytokines in obesity-related diseases. Horm Res 60 Suppl. 3 (2003) 56-59
19. Milan G., Granzotto M., Scarda A., Calcagno A., Pagano C., Federspil G., et al. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes Res 10 (2002) 1095-1103
20. Naderali E.K., Estadella D., Rocha M., Pickavance L.C., Fatani S., Denis R.G., et al. A fat-enriched, glucose-enriched diet markedly attenuates adiponectin mRNA levels in rat epididymal adipose tissue. Clin Sci (Lond) 105 (2003) 403-408
21. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
22. Parker L.A., and Mechoulam R. Cannabinoid agonists and antagonists modulate lithium-induced conditioned gaping in rats. Integr Physiol Behav Sci 38 (2003) 133-145
23. Peirson S.N., Butler J.N., and Foster R.G. Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis. Nucleic Acids Res 31 (2003) e73
24. Ravinet Trillou C., Arnone M., Delgorge C., Gonalons N., Keane P., Maffrand J.P., et al. Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol 284 (2003) R345-R353
25. Rinaldi-Carmona M., Barth F., Heaulme M., Alonso R., Shire D., Congy C., et al. Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci 56 (1995) 1941-1947
26. Rowland N.E., Mukherjee M., and Robertson K. Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats. Psychopharmacology (Berl) 159 (2001) 111-116
27. Scherer P.E., Williams S., Fogliano M., Baldini G., and Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270 (1995) 26746-26749
28. Shklyaev S., Aslanidi G., Tennant M., Prima V., Kohlbrenner E., Kroutov V., et al. Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. Proc Natl Acad Sci U S A 100 (2003) 14217-14222
29. Statnick M.A., Beavers L.S., Conner L.J., Corominola H., Johnson D., Hammond C.D., et al. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res 1 (2000) 81-88
30. Stefan N., and Stumvoll M. Adiponectin-its role in metabolism and beyond. Horm Metab Res 34 (2002) 469-474
31. Thornton-Jones Z.D., Vickers S.P., and Clifton P.G. The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food. Psychopharmacology (Berl) 179 (2005) 452-460
32. Verty A.N., McFarlane J.R., McGregor I.S., and Mallet P.E. Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake. Endocrinology 145 (2004) 3224-3231
33. Verty A.N., McGregor I.S., and Mallet P.E. Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats. Neurosci Lett 354 (2004) 217-220
34. Vickers S.P., and Kennett G.A. Cannabinoids and the regulation of ingestive behaviour. Curr Drug Targets 6 (2005) 215-223
35. Vickers S.P., Webster L.J., Wyatt A., Dourish C.T., and Kennett G.A. Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. Psychopharmacology (Berl) 167 (2003) 103-111
36. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 (2001) 1930-1935
37. Williams C.M., and Kirkham T.C. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 143 (1999) 315-317
38. Williams C.M., and Kirkham T.C. Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav 71 (2002) 333-340
39. Zhang Y., Matheny M., Zolotukhin S., Tumer N., and Scarpace P.J. Regulation of adiponectin and leptin gene expression in white and brown adipose tissues: influence of beta3-adrenergic agonists, retinoic acid, leptin and fasting. Biochim Biophys Acta 1584 (2002) 115-122